INTRODUCTION
Like many other cells of the myeloid lineage, mast cells stand at the interface between innate and adaptive immunity. They contribute to anti-infectious defense when pathogens interact directly with specific receptors [1] or indirectly through the binding of bacterial products to Tolllike receptors (TLRs) [2, 3] . They initiate the allergic reaction when their high-affinity IgE receptors (FcεRI) [4] , which are constitutively occupied by IgE antibodies, are aggregated by a multivalent allergen [5] . They also initiate IgG-dependent inflammatory responses when immune complexes aggregate their low-affinity IgG receptors (FcγRIIIA in mice) in murine models of autoimmune diseases [6] . Mast cell biology has therefore been actively investigated, in mice, rats and humans.
Mast cells are widely distributed among tissues, in virtually all organs [7] . In all cases, however, mast cells represent a minor population. Sources of homogenous mast cells have therefore been searched for and used for experimental studies. Methods based on differential sedimentation in high-density medium have proved useful to obtain reasonably pure ex vivo mature tissue mast cells [8] [9] [10] . One such method is described here. The major limitation of these techniques is their poor yield, making biochemical analyses difficult. For this reason, transformed mast cell lines of various origins have been extensively used. The most popular has been the Rat Basophilic Leukemia (RBL) cell line, which was understood to be a mucosal-type immature rat mast cell line [11, 12] . RBL cells have been invaluable for the biochemical characterization and the cloning of FcεRI subunits [13] , as well as the dissection of proximal signaling following FcεRI aggregation [14] . RBL has also been widely used for transfection of cDNAs and for the mutagenesis analysis of the functional properties of a variety of membrane receptors. A few mouse and human tumor mast cell lines have been described, often lacking FcεRI [15] [16] [17] [18] [19] [20] . In any case, tumor mast cells are not suitable for addressing issues such as differentiation and proliferation. Cultured mast cells, derived from various sources of precursor cells permitted such studies. Hematopoietic stem cell-derived Mast Cells from mice (mBMMC) [21] , rats (rBMMC) [22] or from humans (HMC) [23] have been instrumental for 10. PBS containing 0,1% human AB serum 11. PBS containing 0.1% NaN 3 and 2% paraformaldehyde 3. METHODS
Mouse mast cells

Ex vivo mouse mast cells
Mouse mast cells can be purified from cells recovered by peritoneal washing, among which they represent 3-4% of total cells. 1. Lethally anesthetized 6-9 week-old mice are injected intraperitoneally with 2 mL Tris-A-EDTA buffer. Following careful massage of the abdomen, the abdominal cavity is opened and the fluid is recovered with a Pasteur pipette.
2. Cells are washed once and resuspended at 1 x 10 7 /mL in the same buffer at room temperature.
3. Aliquots of 2 mL peritoneal cell suspension are gently layered over 1.5 mL of 22.5% metrizamide dissolved in Tris-A-EDTA buffer, in siliconized tubes, and centrifuged at 270 g for 10 min at room temperature. Most cells sediment at the interface above metrizamide, while mast cells sediment at the bottom of the tube.
The upper layer, the interface (containing cells) and most of the metrizamide solution are
VERY carefully discarded, leaving 50-100 µL above the small mast cell pellet 4 . Pelleted cells are gently resuspended and transferred into new tubes.
5. Under these conditions, 1 x 10 5 mast cells (>95% pure) can be recovered per mouse.
Cultured mouse mast cells
Mouse Bone Marrow-derived Mast Cells (mBMMC)
Bone marrow (BM) cells are harvested from the femurs of 6-9 week-old mice.
1. After lethal anesthesia of the animals, femurs are carefully dissected to eliminate any muscle fragment.
2. One extremity is cut with sterile scissors, and the needle of a 10-mL syringe, previously filled with sterile RPMI is inserted in the medullar canal. Bone marrow cells are flushed out and collected in a sterile 15-mL tube. 7. mBMMC thus obtained keep growing in IL-3 containing medium for at least 2-3 months 5,6 .
Identifying and phenotyping mouse mast cells
Wright-Giemsa staining
1. Cells are resuspended at 2x10 5 cells/mL in RPMI.
2. One hundred µL suspension are placed in cytospin chambers, mounted onto clean slides.
Slides are spun at 14 g for 5 min.
3. They are air-dried and stained with Wright-Giemsa before they are mounted in 1-2 drops Permount under a cover slip.
Toluidine Blue staining
1. Cytospin slides prepared as above are fixed by adding several drops of Mota's fixative to cover the cells for 10 min. NB: Mota's evaporates quickly, so additional drops must be added once or twice to prevent crystal formation.
2. Fixative is removed by slowly running water down, not directly on cells, and slides are dried.
3. Cells are stained for 20 min with 2-3 drops of acidic toluidine blue.
4.
Stain is removed by running water down the slide.
5.
Slides are air dried and mounted in 1-2 drops Permount under a cover slip 6 . 
Analysis of the Expression of FcεRI and Kit by Immunofluorescence
Rat mast cells
Ex vivo rat mast cells
The same procedure as that described for mouse mast cells can be applied to rat peritoneal cells.
Due to the body weight of rats, mast cells can be obtained in relatively high numbers 4 . 1 . Bone marrow cells are obtained from outbred male Wistar rats, 10-15 week-old (weight 225-250 g) with the same method as for mouse mast bone marrow cells except for the following points. 6. Percentage of mast cells is determined by differential counts (400 cells) on Wright-Giemsa and toluidine blue stained cytocentrifuge preparations. 7. Rat BMMC proliferate rapidly initially, representing 85% of cells after approximately 15 days. After this, the percentage of BMMC increases slowly to almost 100% before cell viability declines around the fifth week 7 8 .
Cultured rat mast cells
Human mast cells
Ex vivo human mast cells
Mast cells with different phenotypes can be purified from various human tissues, including lung, intestine, uterus, skin or foreskin. The general protocol comprises a first step of enzymatic treatment of the desired tissue, in order to obtain a monocellular suspension. This enzymatic treatment is followed by a first step of purification by centrifugation over Percoll gradient and mast cells are further enriched by separation from contaminating cells using anti c-kit immunomagnetic beads 9 .
Tissue processing
Human mast cells are isolated under sterile conditions by a four-step enzymatic tissue dispersion method.
1. Macroscopically normal human tissue is obtained from surgical specimens.
2. The tissue is placed in TE buffer at 4°C immediately after resection until dissection is started.
3. If present (human intestine) the mucosa is separated mechanically from the submucosa/muscular layers. Always for intestine specimen, mucus is removed by incubation with acetylcysteine at 1 mg/mL, and epithelial cells are detached with 5 mM EDTA. 4 . Whatever the nature of the specimen used, the tissue is enzymatically digested by a fourstep incubation (each for 30 min) with four enzymes (3 mg/mL pronase corresponding to 21 U/mL, 0.75 mg/mL chymopapain corresponding to 0.39 U/mL, 1.5 mg/mL collagenaseD corresponding to 0.405 U/mL, and 0.15 mg/mL elastase corresponding to 15.75 U/mL).
During the first digestion step, the tissue (mucosa, in case of intestinal specimen) is chopped finely with scissors. For the third and fourth digestion steps, the incubation buffer is supplemented with DNase at 15 µg/mL corresponding to 15 U/mL.
5.
The cells freed after the last two digestion steps are separated from tissue fragments by filtration through a polyamide Nybolt filter (pore size, 300 µm), washed, pooled, and counted after staining with Turk's solution.
Enrichment of mast cells
Cells are fractionated on discontinuous Percoll gradients and further enriched in mast cells by separation from contaminating cells using immunomagnetic beads. 1. CD34 positive cells are cultured at 37°C in a humidified atmosphere containing 5% CO2 at a starting density of 1 x 10 5 cells/mL in SFCM.
Cultured human mast cells derived from hematopoietic progenitors
2. CD34 + cells may initially proliferate 100 times or more the starting number of cells if rhSCF is combined with rhIL-3 and rhIL-6. Luxurious growth is observed during the first 2-3 wk, although debris will begin to accumulate because of non-mast cell lineage apoptosis and necrosis.
3. Adherent macrophages also may start increasing in number by 2 wk. Check cultures weekly and separate nonadherent mast cell-committed progenitors from adherent cells and debris. HHPMC with less than 5% contamination with other cell types.
5.
Immunostaining for tryptase can be also used to further identify mast cells in the cultures.
Briefly, cytocentrifuged preparations are fixed in cold acetone for 30 min, air-dried, then stored at -20°C. Fixed samples are then treated with mouse IgG1 anti-tryptase monoclonal antibodies, and finally submitted to a Fast-Red immunostaining.
6. After >10 weeks in culture, more than 95 % of the cells are identified as mast cells by their morphological features, the presence of metachromatic granules and their positivity for tryptase. These cells can then used for subsequent experiments as pure normal HMC 11 12 .
7.
Since CD34 positive-derived mast cells usually do not express spontaneously a significant amount of FcεRI at their membrane, they can be incubated for 5 additional days with 2-10 µg/mL of human myeloma IgE and 20 ng/mL of recombinant human IL-4 (rhIL-4) in order to enhance the expression of FcεRI on their membrane.
MUST be discarded. This is why siliconized tubes are used. Carefully wiping tube walls before collecting mast cell pellets may also improve purity.
5.
Bone marrow cells can be kept frozen in liquid nitrogen before they are cultured. When frozen, mBMMC quickly die upon thawing. 6 . Mast cell numbers are calculated by determining the percentage of acidic toluidine blue positive cells out of total Wright-Giemsa-positive cells. Toluidine blue should stain mast cells red-purple (metachromatic staining) and the background blue (orthochromatic staining). Metachromasia, tissue elements staining a different color from the dye solution, is due to the pH, dye concentration and temperature of the basic dye. Blue or violet dyes will show a red color shift, and red dyes will show a yellow color shift with metachromatic tissue elements.
7. Rat bone marrow cells can be kept frozen in liquid nitrogen before they are cultured, but it is impossible to keep rBMMC frozen. 8 . Mast cell numbers are calculated exactly as described above for mBMMC cultures. 9. Isolated human mast cells cannot be frozen using classical techniques 10. Once purified, CD34+ cells can be kept frozen in liquid nitrogen before they are cultured, whereas it is impossible to keep mature HMC frozen. 11. Isolated human MC can be maintained in culture for up to 3 months in the continuous presence of recombinant human SCF. MC purity increases during culture and reached nearly 100%. During the first week of culture, MC numbers decrease, but after that time they start to proliferate. Cultured MC do not change their histamine content, phenotype or morphology. They are even more responsive towards IgE-dependent stimulation, which causes the release of high amounts of histamine, leukotrienes and cytokines such as TNFalpha and IL-5.
